He said the order would be divided equally between Sanofi-Pasteur, GlaxoSmithKline South Africa and Novartis South Africa.
Motswaledi said his department held meetings with the three companies in this regard.
He added, however, that no orders had yet been confirmed.
Got something to say? 



